Policosanol
Policosanol
A mixture of long-chain alcohols from sugar cane wax that may support healthy cholesterol levels, though research results are mixed.
Policosanol is a mixture of long-chain aliphatic alcohols derived from sugar cane wax (Cuban policosanol), rice bran, or beeswax. Cuban studies showed dramatic cholesterol-lowering effects rivaling statins, but independent studies have failed to replicate these results. It may have modest effects on LDL oxidation and platelet aggregation. The discrepancy between Cuban and international studies remains unexplained.
Mechanisms of Action
HMG-CoA Reductase (Proposed)
May inhibit cholesterol synthesis
LDL Oxidation
May reduce LDL oxidation
Platelet Effects
May reduce platelet aggregation
Recommended Dose
10-20mg daily
Loading: Not required
Optimal Timing
- Evening (cholesterol synthesis peaks at night)
- With dinner
Take with food
Best Form
Sugar cane-derived policosanol
Alternatives: Rice bran policosanol, Beeswax policosanol
Cuban studies used sugar cane-derived form. Other sources may have different efficacy. Quality varies between products.
Duration
Minimum: 8 weeks
Optimal: 24 weeks
Cycling: Not required
Note: Taking in evening aligns with peak cholesterol synthesis. Cuban studies used specific sugar cane-derived policosanol.
Personalized Dosage Calculator
Get a dosage recommendation tailored to your body weight, age, goals, and health profile.
Set up your health profile for personalized recommendations
Cholesterol Support
Possible modest LDL reduction
Antioxidant Effects
Reduced LDL oxidation
Inconsistent Results
Studies show mixed results
Evidence is mixed; other options (berberine, red yeast rice) have stronger evidence
Who Should NOT Take This
- Known allergy or hypersensitivity to Policosanol or related compounds
Drug Interactions
May have additive antiplatelet effects
Possible Side Effects
Tip: Take with food
Warnings
- Independent studies have not replicated Cuban results
- Evidence for cholesterol lowering is inconsistent
- Consider other proven alternatives
Top studies from 40+ peer-reviewed papers
Reza Amini M et al. • Diabetes research and clinical practice (2024)
“All rights reserved.”
Key Findings:
- To assess the effects of policosanol on glucose, we employed a random-effects or fixed-effects meta-analysis approach to examine the weighted mean differences (WMDs) and associated 95 % confidence intervals (CI) before and after policosanol and placebo administration.
- Compared to the control group, policosanol supplementation significantly reduced blood glucose levels (WMD: -2.24 mg/dl; 95 % CI: -4.05, -0.42, P = 0.01).
- Findings from subgroup analysis revealed a significant reduction of policosanol supplementation on glucose levels in period of less than 24 weeks, and in individuals below 50 years of age.
- Additionally, the reduction was statistically significant in dosage of 10 mg/day.
Gholamrezayi A et al. • Complementary therapies in medicine (2024)
“Policosanol supplementation exerts a beneficial effect on liver enzymes as well as ALT and AST concentrations in adults.”
Key Findings:
- The combination of effect sizes, regarding the random-effects model, demonstrated significant changes in ALT serum levels after intervention (WMD: -1.48 U/L; 95% CI: -2.33 to -0.64; P = 0.001), and AST (WMD: -1.10 U/L; 95% CI: -1.70 to -0.51; P < 0.001).
- Policosanol supplementation exerts a beneficial effect on liver enzymes as well as ALT and AST concentrations in adults.
- However, further long-term and well-designed RCTs with better quality are needed to further assess and confirm these results.
Roy G et al. • Nutrients (2021)
“This systemic review shows that the apparent lack of effectiveness of diet manipulation in modulating plasma levels of LDL-C among individuals with HeFH is likely due to biases in study designs, rather than a true lack of effects.”
Key Findings:
- A significant reduction in LDL-C levels was reported in 10 RCTs, including eight dietary supplement interventions (phytosterols, n = 6, omega-3, n = 1; guar gum, n = 1), one food-based intervention and one dietary counseling intervention.
- Studies at low risk of biases were more likely to report significant reductions in LDL-C concentrations, compared with studies at risk of bias (chi-square statistic: 5.49; p = 0.02).
- This systemic review shows that the apparent lack of effectiveness of diet manipulation in modulating plasma levels of LDL-C among individuals with HeFH is likely due to biases in study designs, rather than a true lack of effects.
- The likelihood of reporting significant reductions in LDL-C was associated with the concurrent risk of bias.
Gong J et al. • Molecular nutrition & food research (2018)
“The pooled results supported the lipid-lowering effects and safety of policosanol.”
Key Findings:
- The pooled results supported the lipid-lowering effects and safety of policosanol.
- Because of the high heterogeneity, the better treatment effects observed in the Cuban studies and the inconsistent dose-response relationship, more clinical trials are needed to further confirm the efficacy of policosanol on dyslipidemia.
- Further research warranted to confirm findings
Wang HY et al. • The American journal of the medical sciences (2018)
“Policosanol + fenofibrate combination therapy significantly improved lipid parameters, arterial stiffness, and quality of life, with good tolerability.”
Key Findings:
- There were significant increases in SF-36 scores in the policosanol and policosanol + fenofibrate groups (P < 0.05), and significant improvements of ba-PWV in the 2 groups (P < 0.01).
- Policosanol + fenofibrate combination therapy significantly improved lipid parameters, arterial stiffness, and quality of life, with good tolerability.
- Further research warranted to confirm findings
Study Type Distribution
Goals This Supplement Supports
This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.